Fullerton Fund Management CO Ltd. Natera, Inc. Transaction History

Fullerton Fund Management CO Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$132.23 - $171.87 $39.4 Million - $51.2 Million	-297,706 Reduced 97.95%	6,228 $1.05 Million
Q1 2025 May 15, 2025	SELL	$132.63 - $177.0 $23.1 Million - $30.8 Million	-173,942 Reduced 36.4%	303,934 $43 Million
Q4 2024 Feb 14, 2025	BUY	$117.67 - $174.0 $6.27 Million - $9.27 Million	53,292 Added 12.55%	477,876 $75.6 Million
Q3 2024 Nov 14, 2024	BUY	$97.75 - $129.67 $41.2 Million - $54.6 Million	421,374 Added 13126.92%	424,584 $54 Million
Q2 2024 Aug 14, 2024	BUY	$85.28 - $112.6 $61,316 - $80,959	719 Added 28.86%	3,210 $347,000

Q1 2024 May 15, 2024	BUY	$59.21 - $92.9 $147,492 - $231,413	2,491 New	2,491 $227,000

752

127M

1.13M

449K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $19.8B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Fullerton Fund Management CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Fullerton Fund Management CO Ltd. with notifications on news.